A compliance guide covering AYUSH licensing, destination-country import rules, and the documentation that must accompany every Swarna Yukta export consignment.
Swarna Yukta formulations, which incorporate processed gold as a core ingredient, face a distinctive regulatory landscape when moving across international borders. Exporters must navigate Indian AYUSH licensing requirements, destination-country import rules for precious metals and heavy metals, documentation standards, and pharmacopoeial compliance before a single consignment leaves the warehouse.
Gold-based Ayurvedic preparations sit at the intersection of herbomineral medicine, precious metal trade regulations, and pharmaceutical import controls. Unlike plain herbal extracts, Swarna Yukta formulations contain Swarna Bhasma (calx of gold) or Swarna Pishti as active ingredients. Because gold is both a controlled precious metal and a pharmacologically active substance in Ayurvedic classification, regulatory authorities in the exporting and importing countries treat these products with heightened scrutiny.
The Indian regulatory framework requires that the manufacturer hold a valid AYUSH manufacturing licence covering the specific categories of Swarna Yukta preparations. A licence for Bhasma-Pishti preparations and gold-coated items permits production and supply of these formulations, but the scope of coverage must be confirmed before any export order is placed. The licence number, issuing authority, and scope of coverage should appear clearly in every export documentation file.
A buyer sourcing for export should confirm that the manufacturer's AYUSH licence explicitly covers gold-containing preparations and not merely general herbal products. Raasa Ayurveda, operating from Kanpur with AYUSH manufacturing licence A-4177/2009 and GMP certificate D-5755/09, carries 28 Swarna-Yukta gold-coated formulations within its portfolio of 339 classical preparations.
Before any Swarna Yukta product moves across a border, the manufacturer and the exporting entity must ensure compliance at several regulatory layers. The Drugs and Cosmetics Act, 1940, and the rules framed under it govern the manufacture, sale, and distribution of Ayurvedic, Siddha, and Unani drugs in India. Schedule T of those rules specifies GMP requirements for ASU manufacturing units, and compliance with Schedule T is a prerequisite for obtaining the necessary export documentation.
For export, Form 41 under the Drugs and Cosmetics Act serves as the standard export certificate, sometimes referred to as a No Objection Certificate for export. Buyers should confirm with their manufacturer whether this certificate applies to their specific formulation and destination country. Swarna-containing preparations may additionally require a declaration confirming the form and specification of gold used in the finished product, so that import authorities at the destination can verify the declared ingredient.
FSSAI licensing is relevant where a formulation is classified as a nutraceutical or food supplement in the destination market, though classical Ayurvedic preparations licensed under AYUSH are typically treated as ASU drugs under Indian law. A manufacturer's FSSAI registration number may nonetheless be requested by some importers as part of standard supplier qualification, particularly in markets where the food-drug boundary is differently drawn than in India.
Customs documentation must include the correct HS code for herbomineral Ayurvedic preparations. An incorrect HS code can result in mis-declaration of gold content, triggering customs holds or outright rejection at the destination port. Exporters and their freight forwarders should work directly with the manufacturer to confirm the correct commodity code before finalising the shipping documents.
The destination country's regulatory environment determines the final import status of any Swarna Yukta product. These rules vary considerably across regions and trade partners, and an exporter should map requirements for each market individually rather than applying a single framework.
In Gulf Cooperation Council countries, Ayurvedic preparations are generally regulated as traditional medicines or health supplements. Gold-containing preparations typically require submission to the relevant health authority with a certificate of analysis showing gold content within specified limits, a certificate of origin from India, and, in several Gulf markets, prior product registration before commercial import and distribution are permitted.
In European Union markets, the Traditional Herbal Medicinal Products Directive sets a framework that most classical Ayurvedic preparations find difficult to satisfy. The requirement for demonstrated traditional use over 30 years, with 15 of those years within the EU, is challenging to meet for formulations where gold is an active component. Many exporters opt for food supplement classification in EU markets, though that route carries its own restrictions on health claims and permissible dosage forms.
In the United States, Ayurvedic preparations are not regulated as pharmaceutical drugs by the FDA and may be imported as dietary supplements under DSHEA, provided they meet compositional and labelling requirements. Gold-containing preparations attract particular scrutiny regarding heavy metal concentration limits, and importers should confirm current FDA guidance before finalising any shipment plan.
Southeast Asian markets including Singapore, Malaysia, and Thailand operate their own registration pathways for traditional medicines. Swarna Yukta products typically require registration before retail distribution in these markets, supported by a GMP certificate from the Indian licensing authority, a full batch-specific certificate of analysis, and a detailed ingredient declaration.
A properly documented consignment reduces customs delays and builds confidence with import authorities. The core documents for every shipment of Swarna Yukta formulations should include the following items.
A batch-specific certificate of analysis covering identity tests, purity parameters including a heavy metal profile (lead, mercury, arsenic, cadmium), microbial limits, and a specific test confirming gold content and form. The CoA should reference the pharmacopoeial standards applied, typically the Ayurvedic Pharmacopoeia of India or the Ayurvedic Formulary of India.
A GMP certificate issued by the competent Indian authority confirming that the manufacturing unit operates under Schedule T GMP, with a legible English copy or authorised translation where the destination country's customs authority requires it.
A certificate of origin confirming that the product is manufactured in India, typically issued by a recognised chamber of commerce or the relevant government body.
A manufacturing licence copy confirming that gold-based preparations fall within the scope of the manufacturer's licence.
Standard commercial documents: packing list, invoice, and bill of lading. The invoice should declare the gold-containing ingredient by name and preparation form, for example Swarna Bhasma or Swarna Pishti, to avoid misdeclaration.
Not every Ayurvedic manufacturer produces Swarna Yukta formulations to consistent pharmacopoeial standards. Swarna Bhasma preparation involves multiple puta (incineration cycles) to achieve the required particle fineness and identity test results as specified in the Ayurvedic Pharmacopoeia of India. Shortcuts in puta count or temperature control compromise both product safety and regulatory acceptance in markets where third-party testing is mandatory on arrival.
An exporter evaluating a potential manufacturer should request the standard operating procedure for Swarna Bhasma or Swarna Pishti preparation, the puta count used, the identity test methodology applied, and a recent batch's full certificate of analysis including heavy metal data. A manufacturer offering GMP-certified Ayurvedic contract manufacturing and reliable bulk supply of Swarna Yukta preparations should provide a pre-production sample with full documentation before a production order is confirmed.
Raasa Ayurveda, with seventeen years in classical Ayurveda manufacturing and 28 gold-coated formulations in its catalogue, provides samples and a full certificate of analysis with every consignment. To discuss formulation scope, documentation requirements, and sample arrangements for Swarna Yukta export orders, contact the team in Kanpur at raasaayurveda@gmail.com or call +91 9415128217.
The AYUSH manufacturing licence must cover the gold-coated or Bhasma-Pishti category. Beyond that, a Form 41 export certificate is typically required under the Drugs and Cosmetics Act. Some destination countries additionally require prior product registration before import is permitted, so requirements depend on the market.
A certificate of analysis should cover lead, mercury, arsenic, and cadmium at a minimum, alongside an identity test confirming gold content and form. The Ayurvedic Pharmacopoeia of India specifies the relevant test methods. Importing country authorities may apply their own concentration limits, which can differ from Indian pharmacopoeial standards.
Classification varies by destination. Most markets with a traditional medicines category treat it as a regulated medicine. Some markets classify it as a food supplement if it lacks a drug registration, which restricts permissible health claims. Exporters should map the classification for each target market before placing a production order.
Yes. A GMP-certified contract manufacturer can produce Swarna Yukta formulations to the brand owner's specification, supply a batch-specific certificate of analysis, and assist with documentation. The brand owner typically manages in-country registration and importation, while the manufacturer provides the production, quality documentation, and export certificate support.
Raasa Ayurveda, 49/72-A, Naughara, Kanpur 208001, Uttar Pradesh, India. Telephone +91 9415128217. Email raasaayurveda@gmail.com.